Ian Dunn to Antineoplastic Agents
This is a "connection" page, showing publications Ian Dunn has written about Antineoplastic Agents.
Connection Strength
0.691
-
Checkpoint inhibition in meningiomas. Immunotherapy. 2016 06; 8(6):721-31.
Score: 0.348
-
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Sci Rep. 2021 09 09; 11(1):18009.
Score: 0.125
-
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750.
Score: 0.105
-
Advances in multidisciplinary therapy for meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i18-i31.
Score: 0.104
-
HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy? Eur J Cancer. 2004 Jan; 40(1):56-63.
Score: 0.009